Sodium Thiosulfate (Hope Pharmaceuticals)


Welcome to the PulseAid listing for the Sodium Thiosulfate drug offered from Hope Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hope Pharmaceuticals
NON-PROPRIETARY NAME: Sodium Thiosulfate
SUBSTANCE NAME: SODIUM THIOSULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-02-14
END MARKETING DATE: 0000-00-00


Sodium Thiosulfate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Thiosulfate from Hope Pharmaceuticals
LABELER NAME: Hope Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/mL)
START MARKETING DATE: 2012-02-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60267-705_f9a0cd17-ebd9-4c85-a130-8a7dafdb1255
PRODUCT NDC: 60267-705
APPLICATION NUMBER: NDA203923

Other SODIUM THIOSULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hope PharmaceuticalsSodium Thiosulfate